Summary
President Donald Trump is expected to change the federal classification of marijuana from a Schedule I drug to a Schedule III drug. This move will reduce restrictions on marijuana and is intended to encourage more medical research. The reclassification is expected to be announced through an executive order on Thursday.
Key Facts
- President Trump plans to reclassify marijuana to Schedule III on Thursday.
- A Schedule I drug is currently seen as having no accepted medical use and high abuse potential.
- Schedule III drugs are seen as having moderate to low potential for dependence.
- The reclassification will make it easier to research marijuana's medical uses.
- Some Democrats and Republicans support this change for its potential medical benefits.
- Critics argue U.S. drug scheduling does not affect research in other countries.
- The Biden administration previously recommended this reclassification.
- The timing of the reclassification announcement could potentially change.
